The GEO database of 204 patients with lung adenocarcinoma showed that regucalcin was decreased in the patients with lung cancer, and a higher regucalcin gene expression led to prolonged survival in lung cancer patients [38]. The gene discussed is RGN; the disease is lung adenocarcinoma.